Cargando…
The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease
There is a need for treatment options in patients with type 2 diabetes mellitus and kidney disease to achieve glucose targets without risk of hypoglycemia. This article describes management options for these patients using glucose-lowering therapies, in particular dipeptidyl peptidase-4 inhibitors.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springhouse Corp
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434957/ https://www.ncbi.nlm.nih.gov/pubmed/28225432 http://dx.doi.org/10.1097/01.NPR.0000512253.40369.ab |
| Sumario: | There is a need for treatment options in patients with type 2 diabetes mellitus and kidney disease to achieve glucose targets without risk of hypoglycemia. This article describes management options for these patients using glucose-lowering therapies, in particular dipeptidyl peptidase-4 inhibitors. |
|---|